Allecra Therapeutics Announces Positive Top-Line Results for Phase 3 ALLIUM Clinical Trial of EXBLIFEP® for Complicated Urinary Tract Infections

NEXT STORY
Theratechnologies Announces Financial Results for Fiscal Year 2019
PREV STORY
Teleflex to Present at Barclays Global Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tyme’s SM-88 to be included in Pancreatic Cancer Action Network’s (PanCAN’s) Novel “Precision Promise(SM)” Adaptive Phase II/III Pancreatic Cancer Trial Platform

Innovative trial design intended to accelerate development of pancreatic cancer therapiesPotential pivotal pathway for ...

author_avatar
NASDAQ Market News

Innovation Pharmaceuticals Partnering Provides Momentum For Inflammatory Bowel Disease Programs, Targeting a Substantial and Prized Market with a Large Unmet Patient Need

author_avatar
NASDAQ Market News

Caladrius Biosciences Announces Appointment of Kristen K. Buck, M.D., as Chief Medical Officer

author_avatar
NASDAQ Market News